Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

This study has been completed.
Sponsor:
Collaborators:
Wyeth is now a wholly owned subsidiary of Pfizer
Genzyme, a Sanofi Company
Roche Pharma AG
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00275535
First received: January 10, 2006
Last updated: December 6, 2011
Last verified: December 2011